Lv0
0 积分 2024-09-15 加入
Targeted protein degradation for cancer therapy
2小时前
已完结
IRAK4 inhibitor attenuates inflammation
1个月前
已完结
IRAK4 inhibitor attenuates inflammation
1个月前
已完结
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
2个月前
已完结
Targeting cuproplasia and cuproptosis in cancer
4个月前
已完结
Advances in the Study of Hexokinase 2 (HK2) Inhibitors
4个月前
已完结
Trends in the approval of cancer therapies by the FDA in the twenty-first century
8个月前
已完结
皖公网安备34019202002308
